scholarly article | Q13442814 |
P50 | author | Geraldo Lorenzi-Filho | Q47861827 |
Edgar Toschi-Dias | Q53744724 | ||
Felipe X Cepeda | Q64901166 | ||
P2093 | author name string | Luciano F Drager | |
Cristiane Maki-Nunes | |||
Ivani C Trombetta | |||
Maria Urbana P B Rondon | |||
Carlos E Negrao | |||
Maria-Janieire N N Alves | |||
Ana Maria F W Braga | |||
P2860 | cites work | Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 |
Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired? | Q30482416 | ||
The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome | Q33658835 | ||
Consequences of comorbid sleep apnea in the metabolic syndrome--implications for cardiovascular risk | Q34125056 | ||
Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans | Q34264516 | ||
A mathematical model for the determination of total area under glucose tolerance and other metabolic curves | Q34337929 | ||
Interaction of baroreceptor and chemoreceptor reflexes. Modulation of the chemoreceptor reflex by changes in baroreceptor activity | Q34516803 | ||
Chemoreflexes--physiology and clinical implications. | Q35074428 | ||
Sleep apnea and heart failure: Part I: obstructive sleep apnea | Q35095882 | ||
Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
Sleep apnea is a manifestation of the metabolic syndrome | Q36127164 | ||
Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. | Q40027106 | ||
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea | Q43158435 | ||
Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans | Q43427552 | ||
Increased muscle sympathetic nerve activity predicts mortality in heart failure patients | Q46516811 | ||
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. | Q46525807 | ||
Role of respiratory motor output in within-breath modulation of muscle sympathetic nerve activity in humans | Q48120450 | ||
Early signs of atherosclerosis in obstructive sleep apnea | Q48551584 | ||
Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. | Q48770394 | ||
Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea | Q48777647 | ||
Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans | Q69260081 | ||
Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade | Q70483843 | ||
Exposure to hypoxia produces long-lasting sympathetic activation in humans | Q74542436 | ||
Human obesity is characterized by a selective potentiation of central chemoreflex sensitivity | Q77767159 | ||
P433 | issue | 1 | |
P921 | main subject | metabolic syndrome | Q657193 |
obstructive sleep apnea | Q16606552 | ||
P304 | page(s) | 41-49 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Sleep | Q15716655 |
P1476 | title | Obstructive sleep apnea is associated with increased chemoreflex sensitivity in patients with metabolic syndrome | |
P478 | volume | 36 |
Q34635089 | Age-related reflex responses from peripheral and central chemoreceptors in healthy men. |
Q36340657 | Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP. |
Q28076487 | Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease |
Q34598170 | Chemoreflexes, sleep apnea, and sympathetic dysregulation |
Q34238363 | Combined effects of sleep disordered breathing and metabolic syndrome on endothelial function: the Wisconsin Sleep Cohort study |
Q42064248 | Complementary roles of gasotransmitters CO and H2S in sleep apnea |
Q53681657 | Correlation between metabolic syndrome and sleep apnea. |
Q38585664 | Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals |
Q47957890 | Diet and exercise improve chemoreflex sensitivity in patients with metabolic syndrome and obstructive sleep apnea |
Q89287521 | Diet associated with exercise improves baroreflex control of sympathetic nerve activity in metabolic syndrome and sleep apnea patients |
Q57296058 | High-fat diet increases respiratory frequency and abdominal expiratory motor activity during hypercapnia |
Q64901075 | Identifying the risk of obstructive sleep apnea in metabolic syndrome patients: Diagnostic accuracy of the Berlin Questionnaire. |
Q57028907 | Leptin acts in the carotid bodies to increase minute ventilation during wakefulness and sleep and augment the hypoxic ventilatory response |
Q38204543 | Metabolic syndrome: a sympathetic disease? |
Q35782409 | Obstructive Sleep Apnea Impairs Postexercise Sympathovagal Balance in Patients with Metabolic Syndrome. |
Q38608690 | Obstructive sleep apnea does not impair cardiorespiratory responses to progressive exercise performed until exhaustion in hypertensive elderly. |
Q35704508 | Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome |
Q26746944 | Roles and Mechanisms of Obstructive Sleep Apnea-Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and Prospective |
Q26799361 | Sleep, death, and the heart |
Q37597956 | The Role of Acute Intermittent Hypoxia in Neutrophil-Generated Superoxide, Sympathovagal Balance, and Vascular Function in Healthy Subjects. |
Q48134505 | The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome. |
Q43787103 | Time delay of baroreflex control and oscillatory pattern of sympathetic activity in patients with metabolic syndrome and obstructive sleep apnea |